Atlas Trials

Comparing Re-TACE Versus SABR for Post-prior-TACE Incompletely Regressed HCC: a Randomized Controlled Trial (TASABR)

Clinical trial NCT02921139 · UNKNOWN

Trial details

NCT number
NCT02921139
Sponsor
Dalin Tzu Chi General Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatocellular Carcinoma(HCC)
Start date
2016-11-01
Primary completion
2022-11-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.